Edesa Biotech, Inc. Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
Edesa Biotech, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2023 to Q3 2024.
  • Edesa Biotech, Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending September 30, 2024 was $20K, a 79.9% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)

Edesa Biotech, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $20K -$79.6K -79.9% Sep 30, 2024 10-K 2024-12-13
Q2 2024 $39.6K -$83K -67.7% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $59.9K -$80K -57.2% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $81.6K Dec 31, 2023 10-Q 2024-02-09
Q3 2023 $99.6K Sep 30, 2023 10-K 2023-12-15
Q2 2023 $123K Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $140K Mar 31, 2023 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.